Seeing Is Believing
Currently out of the existing stock ratings of Robert Davies, 6 are a HOLD (85.71%), 1 are a BUY (14.29%).
Analyst Robert Davies, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 33.33% that have a potential upside of 4.9% achieved within 23 days.
Robert Davies’s has documented 18 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on FMS, Fresenius Medical Care at 20-Oct-2023.
Analyst best performing recommendations are on PHG (KONINKLIJKE PHILIPS NV ADR).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 1/31/2023. The price target of $16.28 was fulfilled within 1 day with a profit of $0.43 (2.71%) receiving and performance score of 27.13.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$25.6
$3.44 (15.52%)
$50.41
19 days ago
(06-Nov-2024)
0/12 (0%)
$4.75 (22.78%)
Hold
$23
$0.84 (3.79%)
$22
1 months 18 days ago
(07-Oct-2024)
5/12 (41.67%)
$2.41 (11.70%)
144
Hold
$34
1 years 1 days ago
(24-Nov-2023)
0/2 (0%)
$15.46 (83.39%)
$36.47
$14.31 (64.58%)
$50.57
1 years 16 days ago
(09-Nov-2023)
4/15 (26.67%)
$19.39 (113.52%)
137
Sell
$29.84
$7.68 (34.66%)
$33.99
1 years 22 days ago
(03-Nov-2023)
3/15 (20%)
$12.41 (71.20%)
116
What Year was the first public recommendation made by Robert Davies?